Psychiatry and Neurology, Neurology · Northbrook, IL
NPI
1710971700
Since 2005
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1535 Lake Cook Rd, Suite 601
Northbrook, IL, 60062
Phone (847) 509-0270
Groups this clinician bills Medicare through
Medicare paid, 2024
$49K
460 services
Medicare patients, 2024
253
Average age 70
Drug cost, 2024
$4.1M
2,687 prescriptions
Company payments, 2025
$71K
From 48 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Daniel R Wynn was code 99215 (office e&m - established), 320 times for 194 patients. In total Daniel R Wynn billed 460 services in 18 codes, and Medicare paid $49K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-02-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 320 | 194 | $115.20 | $37K |
| 99214 Office E&M - Established | Office | 57 | 47 | $81.20 | $4,628 |
| 99205 Office E&M - New | Office | 35 | 34 | $161.20 | $5,642 |
By year: 2022 $90K for 5,366 services; 2023 $87K for 5,229 services; 2024 $49K for 460 services.
Medicare prescription drug claims, 2024
In 2024, the drug Daniel R Wynn prescribed most often to Medicare patients was Baclofen, with 186 prescriptions and refills. In total Daniel R Wynn wrote 2,687 Medicare prescriptions that cost $4.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Baclofen Generic | 186 | 360 | 46 | $4,950 |
| Teriflunomide Generic | 135 | 207 | 26 | $567K |
| Escitalopram Oxalate Generic | 121 | 308 | 32 | $1,784 |
| Clonazepam Generic | 117 | 230 | 24 | $897 |
| Gabapentin Generic | 98 | 212 | 33 | $1,803 |
| Dalfampridine Er Dalfampridine | 95 | 194 | 23 | $90K |
| Nuedexta Dextromethorphan Hbr/Quinidine | 92 | 120 | 17 | $182K |
| Oxcarbazepine Generic | 90 | 234 | 33 | $6,272 |
| Rebif Interferon Beta-1a/Albumin | 85 | 87 | Under 11 | $927K |
| Topiramate Generic | 85 | 229 | 26 | $1,805 |
| Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine | 81 | 81 | 11 | $1,813 |
| Tizanidine Hcl Generic | 72 | 116 | 21 | $1,333 |
| Copaxone Glatiramer Acetate | 56 | 70 | Under 11 | $404K |
| Ropinirole Hcl Generic | 53 | 115 | 11 | $533 |
| Sumatriptan Succinate Generic | 50 | 64 | 13 | $429 |
Brand drugs: 547 claims; generic drugs: 2,129 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Daniel R Wynn $71K ($68K in general payments such as food, travel and fees and $2,696 for research) from 48 companies. The largest payer was EMD Serono, Inc. with $23K.
| Company | Payments | Amount |
|---|---|---|
| EMD Serono, Inc. MRK.DE | 28 | $23K |
| E.R. Squibb & Sons, L.L.C. BMY | 6 | $9,530 |
| Vanda Pharmaceuticals Inc. VNDA | 28 | $8,540 |
| TG Therapeutics, Inc. TGTX | 20 | $8,097 |
| Mallinckrodt Hospital Products Inc. | 11 | $7,988 |
| Genzyme Corporation SNY | 15 | $7,403 |
| Viatris Specialty LLC | 1 | $1,466 |
| Celgene Corporation BMY | 14 | $613 |
| Pfizer Inc. PFE | 40 | $495 |
| Axsome Therapeutics, Inc. AXSM | 20 | $402 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.